20-38349567-A-G

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1

The NM_004139.5(LBP):​c.144A>G​(p.Leu48Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.939 in 1,608,104 control chromosomes in the GnomAD database, including 710,426 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.90 ( 61637 hom., cov: 31)
Exomes 𝑓: 0.94 ( 648789 hom. )

Consequence

LBP
NM_004139.5 synonymous

Scores

1

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.787

Publications

16 publications found
Variant links:
Genes affected
LBP (HGNC:6517): (lipopolysaccharide binding protein) The protein encoded by this gene is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI), the encoded protein binds LPS and interacts with the CD14 receptor, probably playing a role in regulating LPS-dependent monocyte responses. Studies in mice suggest that the encoded protein is necessary for the rapid acute-phase response to LPS but not for the clearance of LPS from circulation. This protein is part of a family of structurally and functionally related proteins, including BPI, plasma cholesteryl ester transfer protein (CETP), and phospholipid transfer protein (PLTP). [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 20-38349567-A-G is Benign according to our data. Variant chr20-38349567-A-G is described in ClinVar as [Benign]. Clinvar id is 769090.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.787 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.949 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LBPNM_004139.5 linkc.144A>G p.Leu48Leu synonymous_variant Exon 2 of 15 ENST00000217407.3 NP_004130.2 P18428Q8TCF0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LBPENST00000217407.3 linkc.144A>G p.Leu48Leu synonymous_variant Exon 2 of 15 1 NM_004139.5 ENSP00000217407.2 P18428

Frequencies

GnomAD3 genomes
AF:
0.898
AC:
136455
AN:
152028
Hom.:
61600
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.801
Gnomad AMI
AF:
0.954
Gnomad AMR
AF:
0.902
Gnomad ASJ
AF:
0.894
Gnomad EAS
AF:
0.838
Gnomad SAS
AF:
0.869
Gnomad FIN
AF:
0.939
Gnomad MID
AF:
0.807
Gnomad NFE
AF:
0.955
Gnomad OTH
AF:
0.893
GnomAD4 exome
AF:
0.943
AC:
1373147
AN:
1455958
Hom.:
648789
Cov.:
50
AF XY:
0.941
AC XY:
681195
AN XY:
723528
show subpopulations
African (AFR)
AF:
0.793
AC:
26478
AN:
33402
American (AMR)
AF:
0.903
AC:
39653
AN:
43924
Ashkenazi Jewish (ASJ)
AF:
0.896
AC:
23279
AN:
25972
East Asian (EAS)
AF:
0.849
AC:
33571
AN:
39540
South Asian (SAS)
AF:
0.877
AC:
74423
AN:
84894
European-Finnish (FIN)
AF:
0.941
AC:
49514
AN:
52636
Middle Eastern (MID)
AF:
0.827
AC:
4763
AN:
5758
European-Non Finnish (NFE)
AF:
0.961
AC:
1066228
AN:
1109658
Other (OTH)
AF:
0.918
AC:
55238
AN:
60174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
4208
8416
12625
16833
21041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21582
43164
64746
86328
107910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.897
AC:
136545
AN:
152146
Hom.:
61637
Cov.:
31
AF XY:
0.896
AC XY:
66691
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.801
AC:
33231
AN:
41488
American (AMR)
AF:
0.902
AC:
13780
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.894
AC:
3103
AN:
3470
East Asian (EAS)
AF:
0.838
AC:
4312
AN:
5144
South Asian (SAS)
AF:
0.870
AC:
4197
AN:
4822
European-Finnish (FIN)
AF:
0.939
AC:
9954
AN:
10604
Middle Eastern (MID)
AF:
0.793
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
0.955
AC:
64982
AN:
68024
Other (OTH)
AF:
0.893
AC:
1885
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
663
1326
1990
2653
3316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.933
Hom.:
104106
Bravo
AF:
0.891

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
1.4
PhyloP100
0.79

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1739654; hg19: chr20-36977970; API